GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. (GEHCV) Stock Overview
Explore GE HealthCare Technologies Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
25.5B
P/E Ratio
12.52
EPS (TTM)
N/A
ROE
0.23%
GEHCV Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of GE HealthCare Technologies Inc. (GEHCV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $58.38.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 12.52 and a market capitalization of 25.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
GE HealthCare Technologies Inc. operates as a medical technology, pharmaceutical diagnostics, and digital solutions provider. Its products, services, and solutions enable clinicians to make informed decisions, improving patient care from diagnosis to therapy and monitoring. The company is based in Chicago, Illinois. GE HealthCare Technologies Inc. (NasdaqGS:GEHC.V) operates as a subsidiary of General Electric Company (NYSE:GE).
Peter J. Arduini
51,000
500 W. Monroe Street, Chicago, IL
2022